Most lately, it has been discovered that conolidine and the above derivatives act about the atypical chemokine receptor three (ACKR3. Expressed in comparable parts as classical opioid receptors, it binds to some big selection of endogenous opioids. Unlike most opioid receptors, this receptor acts being a scavenger and would not activate a second me